GLAXOSMITHKLINE S.P.A.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Nov 08, 2007 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 26 Total Citation Count
- Feb 13, 2001 Earliest Filing
- 20 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2007/0259,882 3-SUBSTITUTED QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTSAbandonedJun 26, 07Nov 08, 07[A61K, C07D, A61P]
2007/0197,603 Substituted indole ligands for the orl-1 receptorAbandonedJul 01, 04Aug 23, 07[A61K, C07D]
2007/0161,647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTSAbandonedMar 13, 07Jul 12, 07[A61K, C07D]
2006/0229,315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor AntagonistsAbandonedJun 28, 06Oct 12, 06[A61K, C07D]
2005/0176,762 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonistsAbandonedApr 06, 05Aug 11, 05[A61K, C07D]
2004/0082,589 Quinoline derivatives as nk-3 and nk-2 antagonistsAbandonedOct 23, 03Apr 29, 04[A61K, C07D]
2004/0077,658 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonistsAbandonedOct 23, 03Apr 22, 04[A61K, C07D]
6362199 Tetrahydroquinoline derivatives as glycine antagonistsExpiredFeb 15, 01Mar 26, 02[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.